The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer. Novo Nordisk A/S, Jorgensen, Lars Fruergaard, Appointments and Executive Changes, Drugs (Pharmaceuticals), Ozempic (Drug), GLP-1 RAs (Drug), Stocks and Bonds Read More
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
